Among the signaling pathways that are modified in CRC carcinogenesis are those that result in activation of prosurvival, proproliferative, and metastasis (i.e., Wnt, EGFR, and TGF-β) as well as impairment of p53 function [34, 226]. Here, EGFR is linked to colorectal carcinoma.